CD8A and neoplasm: Although Tang et al.[32] have confirmed that APOE inhibitors combined with ICIs have anti‐tumor effects, our study further demonstrated that the combination can decrease M2 and CD8+ Tex cells in TNBC, which may be a crucial mechanism for enhancing the response of ICIs.